Comparison of morning Basal + 1 rapid insulin therapy (Insulin Glulisine + Insulin glargine 300 U/ml vs. Insulin lispro + Insulin glargine BS) using continuous glucose monitoring (CGM):randomised crossover study
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000022094
- Lead Sponsor
- General Inuyamachuo Hospital Department of Diabetes
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
severe renal dysfunction (serum creatinine level over 2.0 mg/dL) judged to be unsuitable for participation for medical reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method